HYCAMTIN 0.25 mg (Hycamtin 0.25 mg)
Generic Name: topotecan
Pill with imprint HYCAMTIN 0.25 mg is White, Capsule-shape and has been identified as Hycamtin 0.25 mg. It is supplied by GlaxoSmithKline.
Hycamtin is used in the treatment of small cell lung cancer; ovarian cancer; cervical cancer; cancer and belongs to the drug class miscellaneous antineoplastics. There is positive evidence of human fetal risk during pregnancy. Hycamtin 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for HYCAMTIN 0.25 mg
Hycamtin
- Generic Name:
- topotecan
- Imprint:
- HYCAMTIN 0.25 mg
- Strength:
- 0.25 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antineoplastics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4205
- Inactive Ingredients:
-
Note: Inactive ingredients may vary.
More about Hycamtin (topotecan)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Generic Availability
- Drug class: miscellaneous antineoplastics
Consumer resources
- Hycamtin oral/injection
- Hycamtin (Topotecan Capsules)
- Hycamtin (Topotecan Injection)
- Hycamtin (Advanced Reading)
- Hycamtin Intravenous (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
